Skip to main content

Table 3 Prevalence of CTC graded GI and GU toxicities

From: Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm3)

Toxicity Grade Start 1 3 6 9 12 18 24
Diarrhea 0 100% 53% 84% 75% 83% 88% 94% 94%
  1 0% 35% 16% 23% 15% 12% 6% 6%
  2 0% 12% 0% 2% 2% 0% 0% 0%
Proctitis 0 86% 79% 93% 92% 100% 98% 100% 100%
  1 14% 21% 7% 8% 0% 2% 0% 0%
  2 0% 0% 0% 0% 0% 0% 0% 0%
Rectal Bleeding 0 100% 91% 95% 100% 98% 98% 96% 96%
  1 0% 9% 5% 0% 2% 2% 4% 4%
  2 0% 0% 0% 0% 0% 0% 0% 0%
Highest GI 0 67% 46% 77% 75% 82% 86% 91% 91%
  1 33% 42% 23% 23% 16% 14% 9% 9%
  2 0% 12% 0% 2% 2% 0% 0% 0%
Hematuria 0 98% 95% 93% 94% 91% 90% 91% 94%
  1 2% 5% 4% 2% 4% 4% 7% 2%
  2 0% 0% 4% 2% 4% 4% 0% 2%
  3 0% 0% 0% 2% 2% 2% 2% 2%
Dysuria 0 89% 65% 77% 90% 80% 92% 91% 92%
  1 11% 35% 23% 10% 20% 8% 9% 8%
  2 0% 0% 0% 0% 0% 0% 0% 0%
Incontinence 0 75% 67% 71% 79% 74% 77% 76% 73%
  1 21% 30% 27% 17% 24% 21% 19% 27%
  2 4% 4% 2% 4% 2% 2% 6% 0%
Urinary frequency/ urgency 0 39% 16% 55% 62% 48% 52% 48% 58%
1 61% 82% 45% 35% 50% 44% 48% 42%
2 0% 2% 0% 4% 2% 4% 4% 0%
Retention 0 67% 33% 57% 54% 57% 56% 54% 44%
  1 33% 26% 20% 21% 19% 15% 19% 29%
  2 0% 53% 29% 30% 29% 31% 31% 36%
  3 0% 0% 0% 0% 0% 2% 2% 2%
Highest GU 0 33% 5% 25% 32% 26% 32% 32% 37%
  1 63% 53% 51% 46% 49% 42% 39% 35%
  2 10% 89% 50% 40% 46% 42% 44% 39%
  3 0% 0% 0% 2% 2% 2% 4% 4%